Market Live Email

AstraZeneca delivers dual lung cancer updates, Veritas snaps up Bodycote for £1.65bn

By Iain Gilbert

Date: Tuesday 01 Sep 2026

(Sharecast News) - LONDON PRE-OPEN

The FTSE 100 was expected to open 1.5 points lower ahead of the bell on Tuesday.
STOCKS TO WATCH

Drugmaker AstraZeneca has finalised its exclusive agreement with Dizal Pharmaceutical for worldwide rights to develop and commercialise Zegfrovy, an oral EGFR inhibitor already approved in...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page